Lipocine (LPCN) Current Taxes (2012 - 2016)
Lipocine's (LPCN) quarterly Current Taxes came in at $700.0 in Q1 2016, down 96.08% on a QoQ basis from $17836.0 in Q4 2012.
Lipocine (LPCN) Current Taxes (2012 - 2016) Analysis & Trends
Lipocine (LPCN) has 2 years of Current Taxes data on file, last reported at $700.0 in Q1 2016.
- Quarterly Current Taxes changed N/A year-over-year to $700.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $700.0 (changed N/A YoY) and the FY2012 annual result came in at $17836.0, changed N/A from the prior year.
- Current Taxes retreated to $700.0 in Q1 2016, from $17836.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $17836.0 in Q4 2012 to a low of $700.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Lipocine | 11.37 Mn | -12.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 700.00 |
| Dec 31, 2012 | 17,836.00 |